{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:37:23Z","timestamp":1758281843325,"version":"3.44.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Autoimmune nodopathy (AN), as patients positive for IgG4 autoantibodies against NF155, NF186, CNTN1, or CASPR1, is a distinct form of chronic inflammatory demyelinating polyneuropathy (CIDP) that shares similar clinical and electrophysiological characteristics with Charcot\u2013Marie\u2013Tooth disease type 1 (CMT1). This study aimed to determine the clinical presentation and electrophysiological features of AN and compare them with antibody-negative CIDP and CMT1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We collected clinical data from 29 patients who met the European Federation of Neurological Societies\/Peripheral Nerve Society (EFNS\/PNS) electrophysiological diagnostic criteria for definite CIDP. Autoimmune antibodies (anti-NF155, NF186, CNTN1, and CASPR1) were tested using cell-based assays. Additionally, 17 CMT1 patients, diagnosed with hereditary motor sensory neuropathy type 1, were included. We compared the clinical and electrophysiological characteristics of AN, antibody-negative CIDP, and CMT1 patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 29 CIDP patients, 10 tested positive for autoantibodies (8 for NF155, 1 for CASPR1, and 1 for CNTN1). AN patients had a younger age of onset compared to antibody-negative CIDP and were similar in age to CMT1 patients. Hand tremor was more common in AN patients (60%) compared to antibody-negative CIDP (21%) and CMT1 (5.8%). Conversely, 76.4% of CMT1 patients exhibited cavus foot, significantly higher than the 20% in AN patients. Cerebrospinal fluid (CSF) analysis revealed higher cell count and protein levels in AN patients compared to antibody-negative CIDP and CMT1. AN patients showed poor response to corticosteroids and intravenous immunoglobulin (IVIG), but rituximab was more effective. Electrophysiological findings revealed significantly prolonged distal motor latencies (DML) in the tibial posterior and peroneal nerves, as well as prolonged F-wave latencies in the ulnar and posterior tibial nerves in AN patients than antibody-negative CIDP. In contrast, compared with AN, CMT1 patients showed prolonged DML and significantly reduced motor conduction velocities (MCV) in the median and ulnar nerves. AN patients exhibited sparing of the sural nerve, whereas this phenomenon was not observed in CMT1 patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In young male patients with hand tremors, demyelinating electrophysiological features (especially prolonged DML and F-wave latencies), elevated CSF protein levels, and poor response to corticosteroids, autoimmune nodopathy, AN antibody testing is recommended. Compared to AN, CMT1 patients tend to have a slower disease course, less frequent tremors, and normal CSF protein levels. A median nerve DML greater than 10\u202fms and MCV less than 25\u202fm\/s supports a diagnosis of CMT1.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1617545","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:14:07Z","timestamp":1758168847000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the presentation and electrophysiological characteristics of autoimmune nodopathies in patients with antibody-negative CIDP and CMT1"],"prefix":"10.3389","volume":"16","author":[{"given":"Changdong","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/a-2238-8294","article-title":"Chronische inflammatorische demyelinisierende Polyradikuloneuropathie (CIDP) [chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)]","volume":"92","author":"Kaulen","year":"2024","journal-title":"Fortschr Neurol Psychiatr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1093\/brain\/awq372","article-title":"Neurofascin as target of autoantibodies in Guillain-Barre syndrome","volume":"134","author":"Pr\u00fcss","year":"2011","journal-title":"Brain"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e2218823120","DOI":"10.1073\/pnas.2218823120","article-title":"Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelination","volume":"120","author":"McKie","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11910-023-01264-4","article-title":"Growing spectrum of autoimmune nodopathies","volume":"23","author":"Gupta","year":"2023","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/jnnp-2023-331378","article-title":"Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort","volume":"95","author":"Broers","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jns.12455","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"26","author":"Van den Bergh","year":"2021","journal-title":"J Peripher Nerv Syst"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/jnnp-2021-326889","article-title":"New classification of autoimmune neuropathies based on target antigens and involved domains of myelinated fibres","volume":"93","author":"Uncini","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"002960","DOI":"10.1136\/practneurol-2021-002960","article-title":"Nodal and paranodal antibody-associated neuropathies","volume":"21","author":"Fehmi","year":"2021","journal-title":"Pract Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European federation of neurological societies\/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European federation of neurological societies and the peripheral nerve society \u2013 first revision","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref10","article-title":"Hereditary neuropathy.","volume-title":"Handb Clin Neurol","author":"Pisciotta","year":"2024"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.nrleng.2024.02.008","article-title":"Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease","volume":"40","author":"Sivera Mascar\u00f3","year":"2024","journal-title":"Neurologia (Engl Ed)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial of prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cnp.2019.08.002","article-title":"Value of terminal latency index and sensory electrophysiology in idiopathic and diabetic chronic inflammatory demyelinating polyradiculoneuropathy","volume":"4","author":"Memon","year":"2019","journal-title":"Clin Neurophysiol Pract"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"844036","DOI":"10.3389\/fimmu.2022.844036","article-title":"Two CIDP variants patients with anti-Caspr1 antibodies in South China","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/brain\/awab014","article-title":"Antibodies to the Caspr1\/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"144","author":"Pascual-Go\u00f1i","year":"2021","journal-title":"Brain"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3988\/jcn.2023.0055","article-title":"Clinical features of autoimmune nodopathy with anti-neurofascin-155 antibodies in south Koreans","volume":"20","author":"Lyou","year":"2024","journal-title":"J Clin Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e209725","DOI":"10.1212\/WNL.0000000000209725","article-title":"Antibodies in autoimmune neuropathies: what to test, how to test, why to test","volume":"103","author":"Pascual-Go\u00f1i","year":"2024","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1495205","DOI":"10.3389\/fneur.2024.1495205","article-title":"Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice","volume":"15","author":"Loser","year":"2024","journal-title":"Front Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"577074","DOI":"10.1016\/j.jneuroim.2019.577074","article-title":"Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China","volume":"337","author":"Zhang","year":"2019","journal-title":"J Neuroimmunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e2392","DOI":"10.1212\/WNL.0000000000012932","article-title":"Neurofascin-155 immunoglobulin subtypes: clinicopathologic associations and neurologic outcomes","volume":"97","author":"Shelly","year":"2021","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e200365","DOI":"10.1212\/NXI.0000000000200365","article-title":"The discovery of autoimmune nodopathies and the impact of IgG4 antibodies in autoimmune neurology","volume":"12","author":"Querol","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1129","DOI":"10.1212\/NXI.0000000000001129","article-title":"Clinical and laboratory features in anti-NF155 autoimmune nodopathy","volume":"9","author":"Mart\u00edn-Aguilar","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.3390\/jcm11133679","article-title":"Evaluation and management of cavus foot in adults: a narrative review","volume":"11","author":"Qin","year":"2022","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.clinph.2020.01.013","article-title":"Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins","volume":"131","author":"Kouton","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.5692\/clinicalneurol.cn-001878","article-title":"Rinsho shinkeigaku","volume":"63","author":"Ogata","year":"2023","journal-title":"Clin Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/acn3.51550","article-title":"Clinical and diagnostic features of anti-neurofascin-155 antibody-positive neuropathy in Han Chinese","volume":"9","author":"Wang","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/ene.13079","article-title":"Nerve conduction velocity in CMT1A: what else can we tell?","volume":"23","author":"Manganelli","year":"2016","journal-title":"Eur J Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1589\/jpts.25.1265","article-title":"Electrophysiological evaluation of chronic inflammatory demyelinating polyneuropathy and Charcot-Marie-tooth type 1: dispersion and correlation analysis","volume":"25","author":"Kang","year":"2013","journal-title":"J Phys Ther Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/brainsci12111587","article-title":"Anti-NF155\/NF186 IgG4 antibody positive autoimmune nodopathy","volume":"12","author":"Wang","year":"2022","journal-title":"Brain Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/acn3.51775","article-title":"Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody","volume":"10","author":"Liu","year":"2023","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1617545\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:14:09Z","timestamp":1758168849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1617545\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":31,"alternative-id":["10.3389\/fneur.2025.1617545"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1617545","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"1617545"}}